Schistosoma mansoni: nitrothiazolines and the male tegument.
Within 24 hr of treatment of the mouse host with BW484C, 2-[5-nitro-2-(pivaloylimino)-4-thiazoline-3-yl]diacetamide, pairs of Schistosoma mansoni exhibited "hepatic shift" and began to leave the mesenteric veins. The tegument of the males was altered, both morphologically and physiologically, while that of females was unaffected. This morphological damage to males correlated well with therapeutic efficacy against both sexes in a range of analogues of BW484C. However, parasites removed from mice after treatment but before the hepatic shift and then maintained in vitro were far from moribund as treated males could be maintained for 8 days in vitro, although this was 5 days less than males from untreated mice. Females survived as well as control worms. In contrast, male and female S. mansoni remaining in their host after therapy were invaded by host cells in the liver after 2 days. The morphological effects and reduction of the in vitro survival of males treated in the mouse and removed after 24 hr could be simulated by in vitro exposure for 24 hr to 10(-5) M BW484C. Females were not susceptible to this regime. It was concluded that worm pairs were swept to the liver as a result of drug dependent damage to the tegument of the male and that phagocytic invasion of male and female schistosomes by host cells within the liver was an important factor in the efficacy of BW484C. The biochemical events underlying the effects on the tegument of male worms remain unknown.
D000818:Animals; D005260:Female; D005947:Glucose / Q000378:metabolism; D006003:Glycogen / Q000032:analysis; D007097:Imines / Q000494:pharmacology* / Q000627:therapeutic use; D008099:Liver / Q000469:parasitology; D008297:Male; D051379:Mice; D008854:Microscopy, Electron; D010587:Phagocytosis; D012550:Schistosoma mansoni / Q000187:drug effects* / Q000378:metabolism / Q000648:ultrastructure; D012555:Schistosomiasis mansoni / Q000188:drug therapy* / Q000469:parasitology; D012556:Schistosomicides / Q000494:pharmacology* / Q000627:therapeutic use; D013844:Thiazoles / Q000494:pharmacology* / Q000627:therapeutic use
D007097:Imines; D012556:Schistosomicides; D013844:Thiazoles; C049672:BW 484C; D006003:Glycogen; D005947:Glucose